AptamiR Therapeutics is a biotechnology company focused on developing a treatment for human obesity and related cardiometabolic disorders. It provides microRNA-targeted therapeutics that enhance lipid oxidation and thermogenesis, turning fat-storing white adipocytes into fat-burning adipocytes. The company also offers drug delivery systems that can supply microRNA analogs to adipose tissues or other particular organs and tissues.